The Hyperscaler Signal That Will Define ARTY in 2026
ARTY, the AI infrastructure ETF, surged as investors await the next round of hyperscaler capex guidance. The hypersca...
Learn what determines index weights, including market cap, float, and rebalancing rules.
5,212 articlesARTY, the AI infrastructure ETF, surged as investors await the next round of hyperscaler capex guidance. The hypersca...
The AI revolution is reshaping markets, but chasing hype can cost you. This guide offers a practical, evidence-based ...
Investors are buzzing about SpaceX's ambitious revenue target for 2030 and a bold rival coming from AI. This guide br...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
As AI moves from experiments to real workloads, the need for secure, low-latency data paths grows. This look explores...
Investing in high-growth EV names can be tempting when share prices dip. This guide helps you evaluate should rivian ...
Bitcoin steadies near key levels as risk appetite returns amid mixed geopolitical headlines. This guide breaks down t...
A disciplined, six‑stock dividend plan could turn $100,000 into reliable annual income. Here's the latest layout, yie...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
As markets navigate early-2026 volatility, three dividend-focused ETFs stand out for beginners. Low fees, broad diver...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...